The Valley Desk

NCT03921879 · Interventional trial

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Overall registry status Unknown

Phase 1

Conditions Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Hodgkin, Lymphoma, Non-Hodgkin, Lymphoma, Peripheral T-Cell, Lymphoma, T-Cell

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov